Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples